TNF and neoplasm: Mechanistically, Dectin-1 activation in myeloid cells leaded to increased production of pro-inflammatory cytokines such as IL-12 and TNF-α, which in turn promoted the recruitment and activation of effector T cells within the TME, thereby amplifying anti-tumor immunity.